Research progress on bidirectional mechanisms and intervention strategies of glioma-associated cerebral infarction

To narratively and comprehensively synthesize the bidirectional mechanisms of glioma-associated cerebral infarction, examine how anti-glioma therapies alter the coagulation system, and clarify the implications for thrombotic risk management and integrated treatment. Peer-reviewed literature retrieved from PubMed and Web of Science (inception to August 2026) was synthesized across the procoagulant mechanisms of gliomas, the reverse pro-tumor effects of the post-infarction microenvironment, and the coagulation-related effects of the major anti-glioma drug classes and their interaction with anticoagulation. Glioma cells drive systemic hypercoagulability through tissue factor (TF), podoplanin (PDPN), and neutrophil extracellular traps (NETs). Thrombin enriched in the infarcted niche activates protease-activated receptors (PARs) on glioma cells and, together with inflammatory signaling and stabilized hypoxia-inducible factor-1α (HIF-1α), favors proliferation and invasion, whereas links to stem-cell maintenance and temozolomide resistance remain extrapolated; direct evidence in the reverse, infarction-to-glioma direction is limited. Alkylating agents, anti-angiogenic drugs, and immune checkpoint inhibitors differ in how they shift thrombosis and bleeding risk, and combining them with anticoagulants requires context-specific judgment. The glioma–coagulation–infarction axis offers a framework for integrating molecular mechanisms with bedside decisions, and supports individualized, platelet- and therapy-stratified anticoagulation within coordinated neuro-oncological management.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2026-11-16
DOI
https://doi.org/10.1007/s12672-026-06191-7
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Research progress on bidirectional mechanisms and intervention strategies of glioma-associated cerebral infarction

Lei Li, Jinyu Lu, Xiaoxuan Fan, Yingxin Zhou et al.
Discover Oncology
Glioma Diagnosis and Treatment
article

Research progress on bidirectional mechanisms and intervention strategies of glioma-associated cerebral infarction

Lei Li, Jinyu Lu, Xiaoxuan Fan, Yingxin Zhou, Zhanpeng Chen, Jing Wei
article en

Abstract

To narratively and comprehensively synthesize the bidirectional mechanisms of glioma-associated cerebral infarction, examine how anti-glioma therapies alter the coagulation system, and clarify the implications for thrombotic risk management and integrated treatment. Peer-reviewed literature retrieved from PubMed and Web of Science (inception to August 2026) was synthesized across the procoagulant mechanisms of gliomas, the reverse pro-tumor effects of the post-infarction microenvironment, and the coagulation-related effects of the major anti-glioma drug classes and their interaction with anticoagulation. Glioma cells drive systemic hypercoagulability through tissue factor (TF), podoplanin (PDPN), and neutrophil extracellular traps (NETs). Thrombin enriched in the infarcted niche activates protease-activated receptors (PARs) on glioma cells and, together with inflammatory signaling and stabilized hypoxia-inducible factor-1α (HIF-1α), favors proliferation and invasion, whereas links to stem-cell maintenance and temozolomide resistance remain extrapolated; direct evidence in the reverse, infarction-to-glioma direction is limited. Alkylating agents, anti-angiogenic drugs, and immune checkpoint inhibitors differ in how they shift thrombosis and bleeding risk, and combining them with anticoagulants requires context-specific judgment. The glioma–coagulation–infarction axis offers a framework for integrating molecular mechanisms with bedside decisions, and supports individualized, platelet- and therapy-stratified anticoagulation within coordinated neuro-oncological management.

Discover Oncology
Affiliated Hospital of Shaanxi University of Chinese Medicine (CN), Shaanxi Provincial Hospital of Traditional Chinese Medicine (CN), Shaanxi University of Chinese Medicine (CN)
National Natural Science Foundation of China
Good health and well-being
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon